Celebrating 30 Years

William D. Tap, MD

University of California, Los Angeles

2006

 $

25000

 

Tower Career Development Grant

Myelodysplastic Inhibition of Protein Farnesylation: A Promising and Potentially Unifying Treatment Modality in Sarcomas

Sarcoma is a rare form of cancer that affects individuals of all ages. Its diagnosis often carries a poor prognosis, as the benefit of traditional chemotherapy has been maximized. It is critical that we discover and apply new, more efficacious therapies.Recently, in our laboratory, we have discovered that Sarcoma cells are sensitive to a novel compound that blocks the cancer’s ability to grow and propagate. Currently, we are pursuing this compound as a treatment for patients with Sarcoma. In addition, we are using it as a scientific tool to help us unravel the molecular intricacies of this deadly disease.

Support the Journey

When you donate to Tower, you’re not supporting a single study. You’re part of an ecosystem that believes the next breakthrough is out there, waiting for someone to believe in it first. Every gift puts resources directly behind the discoveries that would otherwise never see the light of day.